Insmed Inc
Veridion Score
Composite trend over time
Why is INSM moving today?
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for INSM.
INSM insider activity
Insmed Inc
2 insiders bought in the last 90 days
Net selling: -$58.0M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-26 | 2026-06-25 | Lewis William | Insider | sell | $106.27 | 1,292 | 258,917 | $137K | SEC Form 4 |
| 2026-06-26 | 2026-06-25 | Lewis William | Insider | sell | $105.27 | 2,456 | 260,209 | $259K | SEC Form 4 |
| 2026-06-26 | 2026-06-25 | Lewis William | Insider | sell | $104.28 | 3,723 | 262,665 | $388K | SEC Form 4 |
| 2026-06-26 | 2026-06-25 | Lewis William | Insider | sell | $103.10 | 1,836 | 266,388 | $189K | SEC Form 4 |
| 2026-06-26 | 2026-06-25 | Lewis William | Insider | sell | $102.34 | 12,091 | 268,224 | $1.2M | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 137 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moINSM contract awards, year to date.
Public federal awards linked to this ticker.
INSM lobbying filings, year to date.
Registered lobbying filings matched to Insmed Inc.